Enclear Therapies

Precision dosing for CNS diseases through innovative neurotechnology platform

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups12 employees language encleartherapies.com

Registered entities

Innovation

14 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 1,929 times.

YearFilings
20203
20214
20228
20238
20246
20259
20263

Social engagement

Social engagement: 1.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

16 investors on record; lead investors include 20/20 HealthCare Partners, Thiel Capital, Presight Capital, Bioverge.

Investor typeCountShare
Venture capital1063%
Other / undisclosed638%
Coming soon